Global Single-Cell RNA Sequencing System Market Strategic Research Report

Scope of the Report

The global Single-Cell RNA Sequencing System market size is predicted to grow from US$ 1,159 million in 2025 to US$ 3,190 million in 2032; it is expected to grow at a CAGR of 16.4% from 2026 to 2032.

In 2025, global Single-Cell RNA Sequencing System production reached approximately 21.55 k units, with an average global market price of around USD 55,000 per unit.

The gross profit margin of major companies in the industry is between 50.00%–66.00%.

Single-Cell RNA Sequencing System is an integrated analytical platform designed to isolate individual cells, prepare sequencing libraries, and generate transcriptomic data at single-cell resolution. The system combines microfluidics or other cell partitioning technologies with molecular biology workflows and bioinformatics analysis to reveal cellular heterogeneity and gene expression profiles. It is widely used in cancer research, immunology, developmental biology, neuroscience, regenerative medicine, and precision medicine. The product scope includes complete single-cell RNA sequencing instruments and integrated analytical systems, excluding standalone sequencing reagents, consumables, and next-generation sequencing instruments.

The industry chain begins with upstream suppliers of microfluidic components, precision optical modules, electronic components, biochemical reagents, enzymes, nucleic acid extraction materials, chips, and software infrastructure. Midstream includes system design, instrument manufacturing, fluidic integration, software development, calibration, and quality assurance. Downstream users include pharmaceutical companies, biotechnology enterprises, hospitals, academic research institutes, clinical laboratories, and contract research organizations. Increasing demand for precision medicine, biomarker discovery, cell atlas projects, and translational research continues to drive market growth and technology upgrades.

Global key Single-Cell RNA Sequencing System players cover 10x Genomics, Inc., Parse Biosciences, Inc., BD Biosciences (Becton, Dickinson and Company), Standard BioTools Inc., Takara Bio Inc., etc.

This report presents a comprehensive overview of the global Single-Cell RNA Sequencing System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Droplet-Based System
• Microwell-Based System
• Microfluidic Chip-Based System

Segment by Library Preparation Method

• 3' End Sequencing System
• 5' End Sequencing System
• Full-Length Transcript Sequencing System

Segment by Cell Throughput

• Low Throughput (<1,000 Cells/Run)
• Medium Throughput (1,000–10,000 Cells/Run)
• High Throughput (>10,000 Cells/Run)

Segment by Application

• Cancer Research
• Immunology Research
• Developmental Biology Research
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Single-Cell RNA Sequencing System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Cancer Research, Immunology Research, Developmental Biology Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact